This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Ventas' Q3 FFO Meet Estimates on Higher Same-Store NOI, View Raised
by Zacks Equity Research
VTR's Q3 results reflect a year-over-year rise in revenues. The total property same-store NOI improves on strong performance across the business segments.
Welltower (WELL) Reports Q3 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
While the top- and bottom-line numbers for Welltower (WELL) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Welltower (WELL) Q3 FFO and Revenues Top Estimates
by Zacks Equity Research
Welltower (WELL) delivered FFO and revenue surprises of 6.73% and 5.38%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Healthpeak's Q3 FFO Beats Estimates, Same-Store NOI Rises
by Zacks Equity Research
DOC's Q3 FFO tops estimates. Results reflect a year-over-year rise in revenues and total merger-combined same-store cash (adjusted) NOI.
What Analyst Projections for Key Metrics Reveal About Welltower (WELL) Q3 Earnings
by Zacks Equity Research
Besides Wall Street's top -and-bottom-line estimates for Welltower (WELL), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2024.
Welltower Stock to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
WELL's Q3 earnings are likely to have benefitted from the rise in the aging population and its high healthcare expenditure. Yet, high interest expenses are a concern.
Key Reasons to Add Iron Mountain Stock to Your Portfolio Now
by Zacks Equity Research
Strong cash flows from the storage and records management businesses, data-center business expansion and healthy balance sheet are likely to support IRM.
Crown Castle Stock Up 14.6% in Three Months: Will It Rise Further?
by Zacks Equity Research
CCI is likely to gain from rising wireless data consumption with the deployment of 5G networks. A solid tenant base and a healthy balance sheet are upsides.
Here's Why Welltower Stock is an Apt Portfolio Pick for Now
by Zacks Equity Research
A rise in healthcare spending by senior citizens, capital-recycling efforts and a healthy balance sheet are likely to support WELL.
WELL Updates Seniors Housing NNN, Plans to Sell Brookdale Portfolio
by Zacks Equity Research
Welltower provides an update on the Seniors Housing Triple-Net portfolio, as well as the sale of Brookdale Portfolio.
Welltower Stock Rallies 39.1% YTD: Will It Continue to Rise?
by Zacks Equity Research
WELL's senior housing operating portfolio is well-positioned to capitalize on an aging population and a rise in senior citizens' healthcare expenditures.
Here's Why You Should Retain Welltower Stock in Your Portfolio
by Zacks Equity Research
WELL's seniors housing operating portfolio is set to benefit from the aging population and rising healthcare spending. However, high competition is a concern.
Welltower's (WELL) Stock Rises 29.3% YTD: Will the Trend Last?
by Zacks Equity Research
Welltower (WELL) is likely to gain from a rise in healthcare spending by senior citizens and capital recycling activities. However, a high interest rate environment adds to its woes.
Host Hotels (HST) Beats Q2 AFFO Estimates, Lowers '24 View
by Zacks Equity Research
Host Hotels (HST) posts better-than-expected Q2 AFFO on higher revenues, aided by improvements in group and contract business. However, it lowers its 2024 guidance.
Welltower (WELL) Q2 FFO Beat Estimates, Same Store NOI Rises
by Zacks Equity Research
Welltower's (WELL) Q2 earnings outshine estimates driven by a rise in revenues. SHO portfolio occupancy improves year over year.
Welltower (WELL) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
The headline numbers for Welltower (WELL) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Welltower (WELL) Tops Q2 FFO Estimates
by Zacks Equity Research
Welltower (WELL) delivered FFO and revenue surprises of 5% and 2.61%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
What's in Store for Extra Space Storage (EXR) in Q2 Earnings?
by Zacks Equity Research
While Extra Space Storage's (EXR) Q2 results are likely to reflect gains from high brand value and a solid presence in key cities, lower new customer rates and high interest rates remain concerns.
What's in Store for Public Storage (PSA) in Q2 Earnings?
by Zacks Equity Research
Public Storage's (PSA) Q2 results are likely to reflect gains from high brand value and solid presence in key cities, though softening in demand and high interest expenses remain concerns.
Stay Ahead of the Game With Welltower (WELL) Q2 Earnings: Wall Street's Insights on Key Metrics
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for Welltower (WELL), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2024.
Pebblebrook Hotel (PEB) Q2 FFO Surpass Estimates
by Zacks Equity Research
Pebblebrook Hotel (PEB) delivered FFO and revenue surprises of 15% and 0.57%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
BXP Gears Up to Report Q2 Earnings: Key Factors to Consider
by Zacks Equity Research
BXP's Q2 earnings are likely to have benefited from healthy demand for premium office and life-science assets. However, high interest rates remain a concern.
Highwoods' (HIW) Q2 FFO Beats Estimates, '24 View Raised
by Zacks Equity Research
Highwoods' (HIW) Q2 FFO surpasses estimates. Results reflect a fall in rental property and other expenses.
Welltower (WELL) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Welltower's (WELL) Q2 earnings are expected to have benefited from the rise in the senior citizen population and this age cohort's high healthcare expenditure. However, high interest expenses remain a concern.
What's in the Cards for Healthpeak (DOC) This Earnings Season?
by Zacks Equity Research
While Healthpeak's (DOC) Q2 earnings are likely to have benefited from the healthy demand for lab real estate assets, high interest expenses raise concern.